CHRISTOPH WESTPHAL

Profile

First Name

: CHRISTOPH

Middle Name

:

Last Name

: WESTPHAL

Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER, DIRECTOR
VERASTEM, INC.
RICHARD ALDRICH, TIMOTHY BARBERICH, PAUL BRANNELLY, CATHY CAREW, AMY C. CAVERS, JOHN K. CLARKE, GINA CONSYLMAN, ROBERT FORRESTER, ANSBERT GADICKE, ROB GAGNON, JOHN GREEN, PIYUSH GUPTA, JOANNA HOROBIN, MICHAEL KAUFFMAN, STEPHEN KRAUS, ALISON LAWTON, JONATHAN PACHTER, DAN PATERSON, LOUISE PHANSTIEL, ERIC ROWINSKY, STEPHEN SHERWIN, M.D., MONICA SINGH, BRIAN STUGLIK, HENRI TERMEER, BRUCE WENDEL
DIRECTOR
OVASCIENCE, INC.
RICHARD ALDRICH, MATTHEW ANGEL, CHRISTOPHER A. BLECK, STEPHEN BRADY, STEPHEN R. BRADY, JEFF CAPELLO, SCOTT CHAPPEL, MICHELLE DIPP, THOMAS W. DUBENSKY, MICHAEL FLANAGAN, STEPHEN KRAUS, ALISON LAWTON, NICHOLAS MAESTAS, THOMAS MALLEY, GEOFFREY NICHOL, CHRISTINE PELLIZZARI, MICHAEL RAAB, WILLIAM DRAKE RICHEY, RONIT SIMANTOV, JOHN SIMON, HARALD STOCK, JONATHAN TILLY, JUSTIN TROJANOWSKI, THOMAS WOIWODE, JOHN DAVID YEE
EXECUTIVE OFFICER, DIRECTOR
FLEX PHARMA, INC.
DAVID J. ARTHUR, TESS BURLESON, TESS K. BURLESON, ARNOLD C. HANISH, PETER BARTON HUTT, STEPHEN KRAUS, PAUL LAMMERS, JONATHAN LIEBER, BRUCE J. MCCREEDY, WILLIAM K. MCVICAR, MARK J. ROSENBLUM
DIRECTOR
RECROS MEDICA, INC.
THOMAS A. ALBRIGHT, MILIND K. AMBE, M.D., DAVID F. HALE, MARK J. KERSLAKE, EDWARD KNOWLTON, M.D., CATHY MCCARTHY, CATHY L. MCCARTHY, KATHLEEN D. SCOTT
DIRECTOR
PYXIS ONCOLOGY, INC.
ROBERT CRANE, JOHN FLAVIN, LUCIO IANNONE, JAK KNOWLES, GOTHAM MAKKER, CHRISTOPHER O?DONNELL, CHRISTIAN SCHETTER, DAVID STEINBERG, LARA SULLIVAN, GEETA VEMURI
DIRECTOR
TSCAN THERAPEUTICS, INC.
TIMOTHY BARBERICH, ROBERT CRANE, DOUG FAMBROUGH, LEA HACHIGIAN, ITTAI HAREL, ANDREW HEDIN, STEVE KRAUS, CAMPBELL MURRAY, NANDITA SHANGARI, BRIAN SILVER, HANNES SMARASON, DAVID SOUTHWELL
DIRECTOR
WEREWOLF THERAPEUTICS, INC.
SAKAE ASANUMA, PATRICK BAEUERLE, DAVID CORDO, DEREK DIROCCO, LUKE EVNIN, DANIEL HICKLIN, ALON LAZARUS, BRIGGS MORRISON, ELISE WANG
EXECUTIVE OFFICER
LONGWOOD FUND V, L.P.
N/A LONGWOOD FUND V GP, LLC
EXECUTIVE OFFICER, DIRECTOR
IMMUNEID, INC.
LEA HACHIGIAN, ITTAI HAREL
DIRECTOR
IMMUNITAS THERAPEUTICS, INC.
LAURA BRASS, JUERGEN ECKHARDT, JEFFREY GOLDBERG, JIAPING GU, LUCIO IANNONE, DAN MATLOFF, AMANDA WAGNER, KAI WUCHERPFENNIG
EXECUTIVE OFFICER
LONGWOOD FUND VI, L.P.
N/A LONGWOOD FUND VI GP, LLC
EXECUTIVE OFFICER
LONGWOOD SPECIAL SITUATIONS FUND, L.P.
N/A LONGWOOD SPECIAL SITUATIONS FUND GP, LLC
DIRECTOR
NEWLEOS THERAPEUTICS, INC.
RAYMOND CAMAHORT, MING CHEAH, DAVID DONABEDIAN, ROBERT HADFIELD, JOHN MCCABE
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-02-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-02-10 
2024-12-19
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2024-01-03 
2022-09-22
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2021-09-27 
2021-08-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-08-10 
2021-01-28
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-01-15 
2021-01-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-29 
2020-08-13
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-08-02 
2020-07-01
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2019-01-22 
2020-02-18
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2019-01-22 
2019-08-15
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-08-02 
2019-07-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-07-11 
2019-07-12
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2019-06-28 
2019-02-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-12-21 
2014-08-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-07-23 
2014-03-06
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2014-02-21 
2013-03-28
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2013-03-18 
2012-08-14
D/A
Link
BIOTECHNOLOGY 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
DECLINE TO DISCLOSE 
Equity 
2012-06-21 
2012-08-03
D/A
Link
BIOTECHNOLOGY 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
DECLINE TO DISCLOSE 
Equity 
2012-06-21 
2012-07-20
D/A
Link
BIOTECHNOLOGY 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
DECLINE TO DISCLOSE 
Equity 
2012-06-21 
2012-07-19
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2012-07-11 
2012-07-05
D
Link
BIOTECHNOLOGY 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
DECLINE TO DISCLOSE 
Equity 
2012-06-21 
2012-04-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-03-29 
2011-11-21
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2011-11-01 
2011-11-10
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2011-11-01 
2011-07-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-07-12